Physician profile
Robert A Giles
NPI 1093759649
$4,663.60
in general payments reported to CMS, 2019-2025
23 companies · $446 in 2025
The $446 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,027 · 2020: $422 · 2021: $405 · 2022: $867 · 2023: $611 · 2024: $887 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,160.43 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $641.90 | 2019-2025 | Andexxa, Fasenra |
| Janssen Pharmaceuticals, INC | $587.87 | 2019-2024 | Xarelto |
| Allergan, INC. | $587.17 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $343.80 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $203.82 | 2019-2023 | |
| Csl Behring | $164.01 | 2022-2025 | Kcentra |
| Pfizer INC. | $154.80 | 2019-2025 | |
| Gilead Sciences, INC. | $152.35 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.66 | 2022 | |
| Bioxcel Therapeutics, INC. | $124.61 | 2023 | Igalmi |
| Shionogi INC | $109.65 | 2024 | Fetroja |
| Regeneron Healthcare Solutions, INC. | $69.22 | 2022 | |
| Inari Medical, INC. | $42.94 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vapotherm INC | $29.73 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $28.83 | 2020-2021 | |
| Chiesi USA, INC. | $28.69 | 2023-2025 | Cleviprex |
| Stryker Corporation | $27.14 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kedrion Biopharma, INC. | $24.31 | 2024 | Albuked, Koate, Rhogam Ultra-Filtered Plus |
| Alexion Pharmaceuticals, INC. | $16.49 | 2021 | |
| Portola Pharmaceuticals, LLC | $14.67 | 2019 | |
| Grifols USA, LLC | $13.91 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Giles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.